Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients

Lignende værker

• A postmenopausal osteoporotic woman losing bone mineral density despite bisphosphonates
  af: Lai, PSM, et al.
  Udgivet: (2013)
• No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients
  af: Misof, Barbara M., et al.
  Udgivet: (2020)
• Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)
  af: Misof, Barbara M., et al.
  Udgivet: (2019)
• Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects
  af: Misof, Barbara M, et al.
  Udgivet: (2015)
• CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with Osteogenesis Imperfecta type VII
  af: Fratzl-Zelman, N, et al.
  Udgivet: (2009)